Not applicableEnded earlyNCT01196780
What this trial is testing
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Anti-TNF Therapy (REPEAT)
Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,240